Sanofi CEO Paul Hudson speaks during the Competing In The Global Marketplace: Strategies for Growth panel, at the Fortune Global Forum on Nov. 11, 2024 in New York City.

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

Paul Hudson, CEO of Sanofi, works in a volatile business. The pharma sector has been very profitable for many decades, and its weight in the economy has grown steadily.

Sanofi Chief Executive Paul Hudson said the Blueprint acquisition had been in the making for a long time and that work started long before last week’s update. “We’ve had a bit of a bumpy ...

Sanofi has doubled down on its partnership with Adagene, investing $25 million in the biotech, taking up its option on a ...

MORRISTOWN − Gov. Phil Murphy joined Sanofi CEO Paul Hudson on May 22 for the formal grand-opening of French pharmaceutical giant Sanofi's new U.S. flagship office , the home for about 2,000 ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the ... “Sanofi still retains a sizable capacity for further acquisitions,” said Chief Executive Officer Paul Hudson.

“Sanofi's 13,000 U.S.-based employees are pioneering the research and development of first- and best-in-class medicines across numerous therapeutic areas,” Sanofi CEO Paul Hudson, said in a ...